학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 227건 | 목록 1~20
Academic Journal
Di Grazia G; Department of Human Pathology 'G. Barresi', University of Messina, Messina, Italy.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Sánchez-Bayona R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Cancer Research Group, Barcelona, Spain.; Casals-Pascual C; Department of Clinical Microbiology, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, Barcelona, Spain.; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, Madrid, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Generali D; SC Oncologia Multidisciplinare, ASST Cremona, Cremona, Italy.; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.; Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Vigneri P; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; University Oncology Department, Humanitas Istituto Clinico Catanese, Misterbianco, Catania, Italy.; Harbeck N; Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.; Cortés J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.; IOB Madrid, Institute of Oncology, Hospital Beata Maria Ana, Madrid, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. schettini@clinic.cat.; SOLTI Cancer Research Group, Barcelona, Spain. schettini@clinic.cat.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. schettini@clinic.cat.; Department of Medical Oncology, Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain. schettini@clinic.cat.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Sanfeliu E; Department of Pathology, Biomedical Diagnosis Center, Hospital Clínic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Martínez-Romero A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Marín-Aguilera M; Reveal Genomics, S.L., Barcelona, Spain.; Cobo S; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; González-Farré B; Department of Pathology, Biomedical Diagnosis Center, Hospital Clínic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Hernandez-Illan E; Molecular Biology Core, Hospital Clinic of Barcelona, Barcelona, Spain.; Jares P; Department of Medicine, University of Barcelona, Barcelona, Spain.; Molecular Biology Core, Hospital Clinic of Barcelona, Barcelona, Spain.; Puig-Butillé JA; Molecular Biology Core, Hospital Clinic of Barcelona, Barcelona, Spain.; Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Gómez-Bravo R; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Tapia M; Medical Oncology, Hospital Clinic of Valencia, Valencia, Spain.; Tebar C; Medical Oncology, Hospital Clinic of Valencia, Valencia, Spain.; Saura C; Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escrivà-de-Romaní S; Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Soberino J; IOB-QuirónSalud, Barcelona, Spain.; Cortés J; IBCC, Barcelona, Spain.; Morales S; Medical Oncology Department, Arnau de Vilanova, Lleida, Spain.; Amillano K; Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Reus, Spain.; Paré L; Reveal Genomics, S.L., Barcelona, Spain.; Villagrasa P; Reveal Genomics, S.L., Barcelona, Spain.; Buckingham W; Reveal Genomics, S.L., Barcelona, Spain.; Pardo F; Reveal Genomics, S.L., Barcelona, Spain.; Parker JS; Reveal Genomics, S.L., Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Ciruelos E; Institut d'Oncologia de la Catalunya Sud (IOCS), Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, Reus, Spain.; Sánchez-Bayona R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Martinez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Cejalvo JM; Medical Oncology, Hospital Clinic of Valencia, Valencia, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Reveal Genomics, S.L., Barcelona, Spain.; Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Martinez-Jañez N; Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; García-Saenz JÁ; Medical Oncology, Hospital Universitario Clinico San Carlos, Madrid, Spain.; Pernas S; Medical Oncology, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Bermejo B; Medical Oncology, Hospital Clinico Universitario. INCLIVA, Medicine department, Universidad de Valencia, Valencia, Spain.; Morales S; Medical Oncology, Hospital Universitario Arnau de Vilanova, Lleida, Spain.; Guerra J; Medical Oncology, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.; Silva J; Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.; Manso L; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Ciruelos E; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Tolosa P; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Sánchez-Bayona R; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Alva M; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Calabuig-Fariñas S; Department of Pathology, Universitat de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red Cáncer-CIBERONC, Madrid, Spain.; Molecular Oncology Laboratory, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; TRIAL Mixed Unit Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; Gallach S; Centro de Investigación Biomédica en Red Cáncer-CIBERONC, Madrid, Spain.; Molecular Oncology Laboratory, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; TRIAL Mixed Unit Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; Muinelo-Romay L; Centro de Investigación Biomédica en Red Cáncer-CIBERONC, Madrid, Spain.; Liquid Biopsy Analysis Unit - Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.; Piñeiro-Yáñez E; Bioinformatics Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.; Caleiras E; Histopathology Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.; Bueno MJ; Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.; Mouron S; Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain.; Quintela-Fandino M; Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain. mquintela@cnio.es.; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. mquintela@cnio.es.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Nucera S; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; Di Grazia G; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Human Pathology 'G. Barresi', University of Messina, Messina, Italy.; Giudici F; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Strina C; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy.; Milani M; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy.; Tancredi R; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy.; Conte B; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.; Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Experimental Therapeutics, European Institute of Oncology, IRCCS, Milan, Italy.; Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario, Madrid, Spain.; Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Clinic Barcelona Comprehensive Cancer Center, Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Arpino G; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Vigneri P; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; Medical Oncology Unit, Istituto Clinico Humanitas, Misterbianco, Catania, Italy.; Cristofanilli M; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, United States.; Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States.; Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Experimental Therapeutics, European Institute of Oncology, IRCCS, Milan, Italy.; Generali D; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE
Academic Journal
Tolosa P; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. pablo.tolosa@salud.madrid.org.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain. pablo.tolosa@salud.madrid.org.; SOLTI Cancer Research Group, Barcelona, Spain. pablo.tolosa@salud.madrid.org.; García-Fructuoso I; Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pascual T; SOLTI Cancer Research Group, Barcelona, Spain.; Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Martínez-Sáez O; Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cejalvo JM; SOLTI Cancer Research Group, Barcelona, Spain.; Hospital Clínico Universitario de Valencia, Valencia, Spain.; Servitja S; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.; Fernández Abad M; Hospital Universitario Ramón y Cajal, Madrid, Spain.; Benitez Fuentes JD; Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.; Brasó-Maristany F; Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Department of Pathology, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, Barcelona, Spain.; Lema L; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Ruano Y; Department of Pathology, Molecular Pathology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.; Parrilla L; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Roncero AM; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Cobos MÁ; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Díaz I; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Centelles López KA; Unidad de Tumores Mamarios, Instituto Nacional de Cancerología, Ciudad de Mexico, México.; Sánchez-Bayona R; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; SOLTI Cancer Research Group, Barcelona, Spain.; Alva M; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Madariaga A; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.; Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain.; Salvador F; SOLTI Cancer Research Group, Barcelona, Spain.; Sánchez-Belmonte A; Vall d ́Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer CIBERONC, Madrid, Spain.; Malumbres M; Vall d ́Hebron Institute of Oncology (VHIO), Barcelona, Spain.; ICREA, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer CIBERONC, Madrid, Spain.; Prat A; SOLTI Cancer Research Group, Barcelona, Spain.; Clínic Barcelona Comprehensive Cancer Center, Hospital Clínic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Ciruelos E; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. eva.ciruelos@gmail.com.; Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain. eva.ciruelos@gmail.com.; SOLTI Cancer Research Group, Barcelona, Spain. eva.ciruelos@gmail.com.; Centro de Investigación Biomédica en Red en Cáncer CIBERONC, Madrid, Spain. eva.ciruelos@gmail.com.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Madariaga A; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain. Electronic address: ainhoa.madariaga@salud.madrid.org.; Sánchez-Bayona R; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Kasherman L; Medical Oncology, St George Hospital, Kogarah, New South Wales, Australia. Electronic address: https://twitter.com/LKasherman.; Estrada-Lorenzo JM; Library and Information Services, 12 de Octubre University Hospital, Madrid, Spain.; Manso L; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Tolosa P; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Alva M; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Lema L; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; González-Deza C; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Ciruelos E; Medical Oncology, 12 de Octubre University Hospital, Madrid, Spain.; Valcarcel D; Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.; Lheureux S; Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada. Electronic address: https://twitter.com/stephanielheur5.; Oza AM; Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
Publisher: Elsevier Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Academic Journal
Aguilera-Buenosvinos I; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.; Martínez-González MA; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.; Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), Madrid, 28029, Spain.; Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, 02115, USA.; Romanos-Nanclares A; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Sánchez-Bayona R; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain.; de Andrea CE; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain.; Centro de Investigación Biomédica en Red, Área de Cáncer, Madrid, 28029, Spain.; Domínguez LJ; Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy.; Faculty of Medicine and Surgery, University of Enna 'Kore', Enna, Italy.; Toledo E; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain. etoledo@unav.es.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain. etoledo@unav.es.; Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), Madrid, 28029, Spain. etoledo@unav.es.
Publisher: Servicio de Publicaciones de la Universidad De Navarra (departamentos de fisiología y nutrición y de bioquimica) Country of Publication: Spain NLM ID: 9812509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-8755 (Electronic) Linking ISSN: 11387548 NLM ISO Abbreviation: J Physiol Biochem Subsets: MEDLINE
Academic Journal
Sánchez-Bayona R; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Martínez-Sáez O; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Romero-Romero D; Hospital Universitario 12 de Octubre, Madrid, Spain.; Seguí E; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Carcelero E; Pharmacy Department, Hospital Clinic, Barcelona, Spain.; Tolosa P; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Soberino J; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain.; Alva M; Hospital Universitario 12 de Octubre, Madrid, Spain.; Pascual T; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Lema L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Garcia-Fructuoso I; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Cobos-Fernandez MA; Hospital Universitario 12 de Octubre, Madrid, Spain.; Rey M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Aguirre A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Madariaga A; Hospital Universitario 12 de Octubre, Madrid, Spain.; Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; González-Deza C; Hospital Universitario 12 de Octubre, Madrid, Spain.; Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Mayhua A; Hospital Universitario 12 de Octubre, Madrid, Spain.; Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Buckingham W; Reveal Genomics, Barcelona, Spain.; Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.; Paré L; Reveal Genomics, Barcelona, Spain.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; Perou CM; Reveal Genomics, Barcelona, Spain.; Maues J; GRASP, Baltimore, MD, USA.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Ciruelos E; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Centro Integral Oncológico Clara Campal HM (CIOCC), Madrid, Spain.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Medicine Department, University of Barcelona, Barcelona, Spain. alprat@clinic.cat.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain. alprat@clinic.cat.; Reveal Genomics, Barcelona, Spain. alprat@clinic.cat.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Agostinetto E; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.; Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France.; Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel.; Hilbers F; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Barcelona, Spain.; Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.; Moore HCF; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.; Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France.; Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy.; Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.; Ferrari A; Hereditary Breast and Ovarian Cancer Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy.; Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel.; Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy.; Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada.; Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy.; Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota.; Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.; Matikas A; Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden.; Rozenblit M; Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut.; Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; De Marchis L; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy.; Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy.; Del Pilar Estevez-Diz M; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.; Rodriguez-Wallberg KA; Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden.; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.; Mrinakova B; First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia.; Meister S; Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany.; Livraghi L; Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy.; Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.; Yerushalmi R; Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel.; De Angelis C; Department of Medical Oncology, University of Naples Federico II, Napoli, Italy.; Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Meattini I; Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy.; Cichowska-Cwalinska N; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Early Phase Clinical Trials Centre, Medical University of Gdańsk, Gdańsk, Poland.; Berlière M; Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Belgium.; Salama M; Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing.; De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.; Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Chiodi C; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Lee YJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Maria C; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France.; Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Cairo Oncology Center, Cairo, Egypt.; Boni L; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Academic Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Clinical & Translational Oncology
r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO: Repositorio Institucional de Producción Científica
검색 결과 제한하기
제한된 항목
[검색어] Sánchez-Bayona, R
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어